Cart
sales@molnova.com
Flavanocorepsin
CAS No. 30382-18-4
Flavanocorepsin( ——— )
Catalog No. M38417 CAS No. 30382-18-4
Isocoreopsin (Flavanocorepsin) is an anticancer agent that can be isolated from Butea monosperma flowers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFlavanocorepsin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsocoreopsin (Flavanocorepsin) is an anticancer agent that can be isolated from Butea monosperma flowers.
-
DescriptionIsocoreopsin (Flavanocorepsin) is an anticancer agent that can be isolated from Butea monosperma flowers.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number30382-18-4
-
Formula Weight434.39
-
Molecular FormulaC21H22O10
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Subramaniyan B, et al. Isocoreopsin: An active constituent of n-butanol extract of Butea monosperma flowers against colorectal cancer (CRC). J Pharm Anal. 2016 Oct;6(5):318-325.?
molnova catalog
related products
-
Naxitamab
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting GD2 with antitumor activity, used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
-
Mepivacaine
Mepivacaine
-
CAY10602
CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate.
